Centhaquin
Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models[1][2].
Product Specifications
Product Name Alternative
Centhaquine; PMZ-2010
UNSPSC
12352005
Hazard Statement
H315, H319, H413
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/centhaquin.html
Purity
99.93
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC1=CC=CC(N(CC2)CCN2CCC3=NC4=C(C=CC=C4)C=C3)=C1
Molecular Formula
C22H25N3
Molecular Weight
331.45
Precautions
H315, H319, H413
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106690/Centhaquin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106690/Centhaquin-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 4
CAS Number
[57961-90-7]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
